Showing results (791-800 of 966) with videos related to
Sort By:
Pageof 97
Nature Reviews. Clinical Oncology|July 13, 2021
The blood-tumour barrier in cancer biology and therapyPatricia S SteegNature Reviews. Clinical Oncology|May 23, 2023
The roles and implications of RNA m6A modification in cancerXiaolan Deng, Ying Qing, David Horne, et al.Nature Reviews. Clinical Oncology|May 25, 2023
Mitigating long-term and delayed adverse events associated with cancer treatment: implications for survivorshipMaryam B Lustberg, Nicole M Kuderer, Aakash Desai, et al.Nature Reviews. Clinical Oncology|October 10, 2019
Oncolysis without viruses - inducing systemic anticancer immune responses with local therapiesOliver Kepp, Aurelien Marabelle, Laurence Zitvogel, et al.Nature Reviews. Clinical Oncology|April 11, 2019
Cell-state dynamics and therapeutic resistance in melanoma from the perspective of MITF and IFNγ pathwaysXue Bai, David E Fisher, Keith T FlahertyNature Reviews. Clinical Oncology|April 27, 2019
Author Correction: Towards individualized therapy for metastatic renal cell carcinomaRitesh R Kotecha, Robert J Motzer, Martin H VossNature Reviews. Clinical Oncology|July 5, 2017
Precision medicine based on epigenomics: the paradigm of carcinoma of unknown primarySebastián Moran, Anna Martinez-Cardús, Stergios Boussios, et al.Nature Reviews. Clinical Oncology|April 12, 2018
The gut microbiota influences anticancer immunosurveillance and general healthBertrand Routy, Vancheswaran Gopalakrishnan, Romain Daillère, et al.Nature Reviews. Clinical Oncology|April 14, 2018
Targeting the tumour stroma to improve cancer therapyKenneth C Valkenburg, Amber E de Groot, Kenneth J PientaNature Reviews. Clinical Oncology|June 7, 2018
Safety of combining radiotherapy with immune-checkpoint inhibitionWilliam L Hwang, Luke R G Pike, Trevor J Royce, et al.Pageof 97